2023
DOI: 10.1016/j.brainres.2022.148189
|View full text |Cite
|
Sign up to set email alerts
|

Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 82 publications
0
4
0
Order By: Relevance
“…In clinical practice, TDS is less effective as a single dose than DZP and more effective when administered chronically; the results of this study appear to reflect this clinical fact 57 . Activation of GR in the PFC, hypothalamus, amygdala, and ventral hippocampus is known to induce anxiety-like behaviors via diverse mechanisms [12][13][14][15] . DSS-treated mice showed increased phosphorylation levels of GR in the PFC and ventral hippocampus (Fig.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In clinical practice, TDS is less effective as a single dose than DZP and more effective when administered chronically; the results of this study appear to reflect this clinical fact 57 . Activation of GR in the PFC, hypothalamus, amygdala, and ventral hippocampus is known to induce anxiety-like behaviors via diverse mechanisms [12][13][14][15] . DSS-treated mice showed increased phosphorylation levels of GR in the PFC and ventral hippocampus (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…In animal studies, intraperitoneal administration of LPS has been reported to act on the adrenal cortex and increase blood corticosterone levels, resulting in anxiety-like behavior 9 11 . Hyperactivation in the brain of the glucocorticoid receptor (GR), a receptor for corticosterone, is implicated in the development of anxiety-like behavior 12 15 . From these findings, it can be surmised that gut microbiota imbalance may adversely affect the brain through elevated serum LPS and corticosterone, leading to anxiety symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…In line with previous studies, in this research, the injury of hippocampal structure and function exhibited depressive-like behaviors, as evidenced SPT, TST, and NSFT tests. Additionally, the deficiency in hippocampal activity is required for anxiety-like behaviors ( Chen et al, 2022 ; Scholl et al, 2022 ). Some studies reported by other groups have indicated that anxiety-like behaviors could be generated through ischemic/reperfusion injury ( Jin et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…The glucocorticoid and serotoninergic systems are widely acknowledged as exerting a pivotal influence on the development of anxiety and depression [ 1 , 2 , 3 , 4 ]. Modifications in glucocorticoid synthesis and release or alterations in the composition of serotonin receptors across various cell subtypes within limbic and thalamocortical brain regions inevitably impact mental states [ 5 , 6 , 7 ].…”
Section: Introductionmentioning
confidence: 99%